A uterine lining of at least 7 to 8 mm is generally considered the minimum threshold for a successful embryo transfer during IVF, with the best implantation rates seen at 9 mm and above. If your clinic has flagged your lining as too thin, there are several medical strategies and supportive measures that can help it grow. Most involve improving estrogen exposure, increasing blood flow to the uterus, or both.
What Thickness Your Clinic Is Looking For
Your fertility team measures your uterine lining (endometrium) via ultrasound in the days leading up to embryo transfer. Research published in Fertility and Sterility found that 8.35 mm is the optimal cutoff for successful implantation. The numbers tell a clear story: women with a lining under 7 mm had a 46.7% implantation rate, while those in the 9 to 12 mm range reached 62%, and women above 12 mm saw rates near 64%.
Thickness isn’t the only thing that matters. The pattern of your lining on ultrasound plays an independent role. A “trilaminar” pattern, where the lining shows three distinct layers resembling a triple stripe, is associated with three times the odds of clinical pregnancy compared to a uniform, homogenous appearance. Women with a trilaminar pattern had a 65.9% pregnancy rate versus 44.8% for those with a homogenous lining. Your doctor looks at both measurements together when deciding whether to proceed with transfer.
Estrogen: The Primary Driver of Lining Growth
Estrogen is the hormone directly responsible for building your uterine lining each cycle. In a frozen embryo transfer, your clinic typically prescribes estradiol (a form of estrogen) to grow the lining on a controlled schedule. Treatment usually begins on day 2 of your menstrual cycle and continues for about 10 days before your lining is reassessed.
Standard oral doses range from 4 to 6 mg per day, split into morning and evening doses. If oral estrogen alone isn’t producing enough growth, your clinic may switch to a different delivery route. Vaginal estradiol tablets or transdermal patches (worn on the skin) bypass the liver and can sometimes deliver estrogen to the uterus more effectively. Some clinics layer multiple routes together, combining oral and vaginal estrogen, when a single route falls short. Your doctor will adjust the dose and route based on your ultrasound measurements at follow-up visits.
Platelet-Rich Plasma (PRP) Infusion
For women whose lining remains stubbornly thin despite adequate estrogen, platelet-rich plasma infusion has become a more widely used option. PRP is made from a small sample of your own blood, which is processed to concentrate the growth factors and healing proteins in your platelets. A small volume, roughly 1.5 to 2 ml, is then infused directly into your uterus through a thin catheter, similar to what’s used during embryo transfer.
The procedure is typically scheduled around day 8 to 10 of your cycle. A follow-up ultrasound is done 2 to 3 days later to check whether the lining has responded. If it remains below 7 mm, a second infusion can be performed within the same cycle. PRP is still considered an adjunct therapy rather than a first-line treatment, but it has shown enough promise that many clinics now offer it for patients who haven’t responded to estrogen alone.
Medications That Improve Blood Flow
A thin lining sometimes reflects poor blood supply to the uterus rather than insufficient estrogen. Several medications target this problem by widening blood vessels and improving circulation to the endometrium.
Vaginal sildenafil (the same compound found in Viagra) is one of the more commonly studied options. It works by relaxing the smooth muscle in blood vessel walls, allowing more blood to reach the uterine lining. It’s applied vaginally so the effect is concentrated in the pelvic area.
Another approach combines pentoxifylline, a medication that improves blood flow by making red blood cells more flexible, with vitamin E, an antioxidant. In clinical use, both are taken at 400 mg twice daily, often starting one to two full menstrual cycles before the IVF treatment cycle begins. This lead time gives the medications a longer window to improve the blood vessel environment in the uterus before the lining needs to grow for transfer.
L-Arginine Supplementation
L-arginine is an amino acid your body uses to produce nitric oxide, a molecule that dilates blood vessels. A randomized controlled trial tested L-arginine supplementation in women with persistently thin linings who hadn’t responded well to standard treatments. Women took 2 grams daily (1 gram every 12 hours), starting in the cycle before embryo transfer.
The results were notable. Average lining thickness went from 3.3 mm before treatment to 7.79 mm after supplementation. That’s a meaningful jump, particularly for women starting well below the 7 mm threshold. L-arginine is available over the counter, but if you’re in an IVF cycle, coordinate with your fertility team before adding it. The timing and dose matter, and it may interact with other medications in your protocol.
What About Exercise and Lifestyle?
The relationship between physical activity and uterine blood flow is less straightforward than many wellness sources suggest. Research on exercise and uterine artery blood flow has produced mixed findings. Moderate recreational physical activity has actually been associated with higher resistance in the uterine arteries in some studies, meaning less blood flow, not more. On the other hand, moderate work-related physical activity (the kind involving sustained movement throughout the day) showed the opposite effect. And several studies found that moderate exercise had no measurable impact on uterine blood flow at all.
The practical takeaway is that gentle, regular movement is unlikely to hurt your lining and supports overall cardiovascular health, but there’s no strong evidence that a specific exercise routine will meaningfully thicken a thin endometrium on its own. Walking, yoga, and light aerobic activity are reasonable during an IVF cycle, though your clinic may advise you to avoid high-intensity workouts close to transfer for other reasons.
When Your Lining Doesn’t Respond
If your lining remains thin after escalating through estrogen adjustments, blood flow medications, and procedures like PRP, your fertility team may recommend canceling the transfer cycle rather than proceeding with a lining that’s unlikely to support implantation. This is frustrating, but transferring an embryo into an inadequately prepared lining risks using an embryo without a realistic chance of success.
In these cases, your doctor will typically investigate underlying causes. Previous uterine surgeries, repeated D&C procedures, or infections can cause scarring (called Asherman syndrome) that physically limits how much the lining can grow. A hysteroscopy, a procedure where a small camera is inserted into the uterus, can identify and sometimes treat adhesions or scar tissue. Chronic low-grade inflammation of the endometrium is another treatable cause that can be identified through a biopsy.
For most women with a thin lining, a combination of optimized estrogen delivery and one or two adjunct therapies is enough to reach the target range. The key is giving your clinic enough information early in the cycle so they can layer in additional interventions before the transfer window closes.